{
    "clinical_study": {
        "@rank": "20228", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. It is not yet known whether ifosfamide or doxorubicin is more\n      effective for advanced or metastatic soft tissue sarcoma.\n\n      PURPOSE: Randomized phase III trial to compare the effectiveness of ifosfamide with that of\n      doxorubicin in treating patients who have advanced or metastatic soft tissue sarcoma."
        }, 
        "brief_title": "Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma", 
        "condition": "Sarcoma", 
        "condition_browse": {
            "mesh_term": "Sarcoma"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the progression free survival rate in patients with advanced or\n      metastatic soft tissue sarcoma treated with either of two different regimens of ifosfamide\n      or doxorubicin. II. Assess the toxic effects of these therapies and response rate in these\n      patients.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are randomized into one of 3 arms\n      (continuous ifosfamide, ifosfamide daily for 3 days, or doxorubicin). Patients are\n      stratified by performance status (0 vs 1), liver involvement (no vs yes), histological type\n      (leiomyosarcoma vs synovial sarcoma vs other), and histological grade (1 vs 2 vs 3). Arm I:\n      Patients receive doxorubicin by bolus infusion for 5-20 minutes once every 3 weeks. Arm II:\n      Patients receive ifosfamide by intravenous infusion for 4 hours on days 1, 2, and 3 every\n      three weeks. Arm III: Patients receive ifosfamide by intravenous infusion for 72 hours every\n      3 weeks. Patients are assessed after every 2 courses of therapy. Each course of therapy\n      consists of 3 weeks of treatment. Patients may receive a maximum of 6 courses of therapy in\n      the absence of toxicity and disease progression. Patients are followed every 12 weeks for\n      survival.\n\n      PROJECTED ACCRUAL: A total of 780 patients (260 per treatment arm) will be accrued for this\n      study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven advanced or metastatic soft tissue sarcoma\n        including the following: Malignant fibrous histiocytoma Liposarcoma Rhabdomyosarcoma\n        Synovial sarcoma Malignant paraganglioma Fibrosarcoma Leiomyosarcoma Angiosarcoma\n        including haemangiopericytoma Neurogenic sarcoma Unclassified sarcoma Mixed mesodermal\n        tumor of the uterus Measurable disease with evidence of progression in prior 6 weeks No\n        symptomatic or known CNS metastases\n\n        PATIENT CHARACTERISTICS: Age: 15 to 65 Performance status: WHO 0-1 Life expectancy: Not\n        specified Hematopoietic: WBC at least 3000/mm3 Neutrophil count greater than 2,000/mm3\n        Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater 1.75 mg/dL Albumin at\n        least 25 g/L Renal: Creatinine clearance greater than 70 mL/min Cardiovascular: No history\n        of uncontrolled cardiovascular disease Other: Fertile women must use effective\n        contraception No other severe medical illness including psychosis No prior primary\n        malignant tumor except: Adequately treated carcinoma in situ of the cervix Basal cell\n        carcinoma\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior\n        chemotherapy Endocrine therapy: Not specified Radiotherapy: No radiotherapy to the sole\n        index lesion Surgery: Not specified"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "780", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003212", 
            "org_study_id": "EORTC-62971", 
            "secondary_id": "EORTC-62971"
        }, 
        "intervention": [
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "ifosfamide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Doxorubicin", 
                "Isophosphamide mustard", 
                "Ifosfamide"
            ]
        }, 
        "keyword": [
            "adult angiosarcoma", 
            "adult fibrosarcoma", 
            "adult leiomyosarcoma", 
            "adult liposarcoma", 
            "adult neurofibrosarcoma", 
            "adult synovial sarcoma", 
            "recurrent adult soft tissue sarcoma", 
            "adult malignant fibrous histiocytoma", 
            "adult malignant hemangiopericytoma", 
            "adult rhabdomyosarcoma", 
            "stage IV uterine sarcoma", 
            "recurrent uterine sarcoma", 
            "stage IV adult soft tissue sarcoma"
        ], 
        "lastchanged_date": "January 19, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-62971"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarhus", 
                        "country": "Denmark", 
                        "zip": "DK-8000"
                    }, 
                    "name": "Aarhus Kommunehospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Rigshospitalet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "D-30625"
                    }, 
                    "name": "Medizinische Hochschule Hannover"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "D-81377"
                    }, 
                    "name": "Klinikum Grosshadern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1125"
                    }, 
                    "name": "National Institute of Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1066 CX"
                    }, 
                    "name": "Antoni van Leeuwenhoekhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2300 CA"
                    }, 
                    "name": "Leiden University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6252 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland", 
                        "zip": "02-781"
                    }, 
                    "name": "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bratislava", 
                        "country": "Slovakia", 
                        "zip": "833 10"
                    }, 
                    "name": "National Cancer Institute - Bratislava"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Palmas", 
                        "country": "Spain", 
                        "zip": "G.C."
                    }, 
                    "name": "Hospital Insular de Gran Canaria"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "LS9 7TF"
                    }, 
                    "name": "St. James's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "WIT 3AA"
                    }, 
                    "name": "Middlesex Hospital- Meyerstein Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SW3 6JJ"
                    }, 
                    "name": "Royal Marsden NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "M20 4BX"
                    }, 
                    "name": "Christie Hospital N.H.S. Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle Upon Tyne", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NE4 6BE"
                    }, 
                    "name": "Newcastle General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NG5 1PB"
                    }, 
                    "name": "Nottingham City Hospital NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "S1O 2SJ"
                    }, 
                    "name": "Weston Park Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Denmark", 
                "France", 
                "Germany", 
                "Hungary", 
                "Netherlands", 
                "Poland", 
                "Slovakia", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma", 
        "overall_official": {
            "affiliation": "Christie Hospital NHS Foundation Trust", 
            "last_name": "Paul C. Lorigan, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2001", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003212"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "17634494", 
            "citation": "Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 2007 Jul 20;25(21):3144-50."
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 1998", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2012"
    }, 
    "geocoordinates": {
        "Aarhus Kommunehospital": "56.163 10.204", 
        "Antoni van Leeuwenhoekhuis": "52.37 4.895", 
        "Centre Leon Berard": "45.764 4.836", 
        "Christie Hospital N.H.S. Trust": "53.479 -2.248", 
        "Hospital Insular de Gran Canaria": "28.125 -15.43", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Klinikum Grosshadern": "48.145 11.558", 
        "Leiden University Medical Center": "52.16 4.494", 
        "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology": "52.23 21.012", 
        "Medizinische Hochschule Hannover": "52.384 9.727", 
        "Middlesex Hospital- Meyerstein Institute": "51.508 -0.128", 
        "National Cancer Institute - Bratislava": "48.146 17.107", 
        "National Institute of Oncology": "47.498 19.041", 
        "Newcastle General Hospital": "54.978 -1.618", 
        "Nottingham City Hospital NHS Trust": "52.955 -1.158", 
        "Rigshospitalet": "55.676 12.568", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "Royal Marsden NHS Trust": "51.508 -0.128", 
        "St. James's Hospital": "53.801 -1.549", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Medical Center Nijmegen": "51.843 5.855", 
        "Weston Park Hospital": "53.381 -1.47"
    }
}